Skip to content

Strength After Elbow Fractures in the Elderly

Strength and Function After Non-operative Treatment of Displaced Olecranon Fractures in the Elderly: Implications of Standing UP From a Seat

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05135949
Acronym
STAND-UP
Enrollment
50
Registered
2021-11-26
Start date
2021-02-22
Completion date
2027-07-01
Last updated
2025-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture;Elbow

Keywords

Operative, Non Operative

Brief summary

Elderly patients strength and function, specifically the ability to rise from a seat after either operative or non operative treatment of an mayo type 2 olecranon fracture.

Detailed description

Elderly patients with an olecranon fracture will receive appropriate treatment as determined by the treating surgeon. Patients will then be assessed at 6 weeks, 6 months and 12 months post treatment. Assessments include, range of motion, patient reported outcomes and a strength test.

Interventions

OTHERPatient Reported Outcomes

Satisfaction, Disabilities of the Shoulder, Arm and Hand

Handheld dynamometer to measure tricep extension

Sponsors

Fraser Orthopaedic Research Society
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum

Inclusion criteria

1. ≥65 years of age 2. Mayo type II olecranon fracture 3. Ambulatory (with or without the use of walking aides)

Exclusion criteria

1. Additional injuries to the affected arm or contralateral arm 2. Associated nerve injury 3. Dementia or cognitive impairment that inhibits the collection of outcome measures 4. Likely problems, in the judgement of the investigator, with maintaining follow-up (i.e. patients with no fixed address, not mentally competent to give consent, intellectually challenged, patients without adequate support, etc.) 5. Injury or previous deficit to the contralateral arm 6. Currently enrolled in any other research study involving drugs or medical devices 7. Open fractures 8. Inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Extension Strength12 MonthsPatients will push down on their distal forearm through a hand held dynamometer, to measure tricep extension strength

Secondary

MeasureTime frameDescription
Arc of Motion12 monthsElbow extension and elbow flexion measured with a goniometer
Mayo Elbow Performance Index12 MonthsAn instrument used to test the limitations, caused by pathology, of the elbow during activities of daily living. Higher scores indicate a better outcome.
Disabilities of the Arm, Shoulder, and Hand12 MonthsA 30 Item questionnaire that measures an individuals' ability to complete tasks, absorb forces and severity of symptoms. Lower scores will indicated better outcomes.Lower scores will indicate better outcomes.
Satisfaction Score6 weeks, 6 months and 12 monthsSoccer out of 10, higher the score the better the outcome

Countries

Canada

Contacts

Primary ContactKyrsten Butterfield, BSc
kyrsten.butterfield@fraserhealth.ca604-553-3247

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026